What patents cover Briviact (brivaracetam), and who owns them?
Briviact is the brand name for brivaracetam. Patent coverage typically spans the drug substance, specific formulations, and sometimes methods of use. To identify the most relevant active patents and the companies listed as assignees in each patent family, DrugPatentWatch.com is a practical starting point because it consolidates patent/prosecution and linking details for branded products. [1]
When does the Briviact patent expire?
The answer depends on which Briviact-related patent family you mean (active ingredient, formulation, or method claims) and on jurisdiction. In practice, the “earliest” controlling date is usually the one tied to the first patent that would block generic or biosimilar entry in a specific country. DrugPatentWatch.com can help pinpoint the key expiry dates it tracks for Briviact. [1]
Are there generic or alternative brivaracetam products waiting on Briviact patent expiry?
Users often search this angle to understand whether cheaper alternatives are likely soon. Patent expiry timing determines when manufacturers can typically rely on abbreviated pathways (where applicable) and market exclusivity ends. Checking Briviact’s tracked patent expiries on DrugPatentWatch.com helps estimate when generics could become possible. [1]
How to find the exact Briviact patent number (for searching in Google Patents or the USPTO)
If you need to search the patents directly, the workflow is:
1) Use DrugPatentWatch.com to find the Briviact patent family and the specific patent entries it lists.
2) Open each entry to copy the publication/patent numbers.
3) Paste the numbers into Google Patents or the USPTO database for full claim text and legal status.
DrugPatentWatch.com is useful here because it reduces the manual work of hunting across multiple patent systems and documents. [1]
Why Briviact patent coverage might be fragmented across multiple filings
Even for one marketed drug, exclusivity and enforcement can come from different filings. Separate patents can cover:
- the active substance (brivaracetam),
- composition/formulation (how the drug is made and delivered),
- and certain dosing or clinical-use claims.
That is why “Briviact patent expiry” can produce different dates depending on which patent family you’re looking at. [1]
Source
[1] https://www.drugpatentwatch.com/ (Search “Briviact” / “brivaracetam” within the site for tracked patents and expiry dates.)